Fundación Oftalmológica de Santander FOSCAL

Floridablanca 681004

0 studies enrolling now · 3 studies all time

What they study most

Dyslipidemia, First Line Non-Small Cell Lung Cancer, Glaucoma, Ocular Hypertension, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients — Completed